Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

New EnCoate CEO looks to global market

New EnCoate CEO looks to global market

15 November, 2007

New EnCoate CEO Simon Yarrow says he is looking forward to helping the bio-polymer company realise its potential to double the global probiotics market through the commercialisation of a revolutionary line of probiotic formulations for enhancing food products.

A Joint Venture Company owned by Ballance Agri-Nutrients, AgResearch and BioPacificVentures, EnCoate's goal is to extend the shelf-life of probiotics to two years at room temperature and humidity with special formulations.

Probiotics are the 'good bacteria' that have been shown to provide a range of human health benefits. Currently probiotics are commonly delivered in dairy products to improve gut health.

Current technology does not allow probiotics to be mixed with other ingredients, which considerably limits the scope of their application. Encoate has developed a technology that can stabilise these microbes so they can be used to enhance foods such as breakfast cereals, infant milk-powders and dog-biscuits.

In July EnCoate announced that it had secured an investment of $6.3 million from BioPacificVentures, the $100 million Venture Capital fund, managed by Auckland firm Direct Capital in collaboration with the global Inventages group fund, which manages $1.5 billion in the life sciences area.

"This investment will give EnCoate the opportunity to commercialise its unique technology. I look forward to working with the EnCoate team and potential collaborators to ultimately bring a product to market," he says.

Simon has considerable industry experience including a stint with Fonterra as Business Manager for its Human Health and Nutrition division and as Regional Marketing Executive for South East Asia. His most recent position was General Manager of Diagnostics at Dairy Farmer Cooperative LIC.

Simon is currently based near the AgResearch Ruakura campus in Hamilton but is considering a move to Lincoln near Christchurch where EnCoate's technology is being developed by a team of scientists from AgResearch's Biocontrol, Biosecurity & Bioprocessing Section.

ENDS


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Voluntary Administration: Renaissance Brewing Up For Sale

Renaissance Brewing, the first local company to raise capital through equity crowdfunding, is up for sale after cash flow woes and product management issues led to the appointment of voluntary administrators. More>>

Elsewhere:

Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:

Media Mega Merger: Full Steam Ahead For Appeal

New Zealand's two largest news publishers have confirmed they are committed to pursuing their appeal against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>